Top 17 Pfizer INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ALLO | ALLOGENE THERAPEUTICS INC | 27.55% | 22.03M | $46.9M | +0.00%(+0) | $2.47(-19.68%) | 2026-06-30 | |
| CELC | CELCUITY INC | 17.35% | 295.7K | $29.6M | +0.00%(+0) | $14.00(+518.57%) | 2026-06-30 | |
| ARVN | ARVINAS INC | 16.24% | 3.46M | $27.7M | +0.00%(+0) | $21.90(-58.86%) | 2026-06-30 | |
| PYXS | PYXIS ONCOLOGY INC | 11.43% | 7.03M | $19.5M | +0.00%(+0) | $2.62(+15.11%) | 2026-06-30 | |
| WVE | WAVE LIFE SCIENCES LTD | 6.42% | 1.88M | $10.9M | +0.00%(+0) | $10.28(-49.44%) | 2026-06-30 | |
| BHVN | BIOHAVEN LTD | 4.7% | 505.6K | $8.0M | +0.00%(+0) | $43.66(-67.18%) | 2026-06-30 | |
| CRBU | CARIBOU BIOSCIENCES INC | 4.63% | 4.69M | $7.9M | +0.00%(+0) | $1.78(-9.30%) | 2026-06-30 | |
| SPRO | SPERO THERAPEUTICS INC | 3.13% | 2.36M | $5.3M | +0.00%(+0) | $1.19(+4.64%) | 2026-06-30 | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 2.26% | 953.8K | $3.9M | +0.00%(+0) | $3.36(+23.70%) | 2026-06-30 | |
| ORIC | ORIC PHARMACEUTICALS INC | 2.09% | 372.9K | $3.6M | -92.20%(-4.41M) | $9.16(+47.98%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +34.29% |
| Top 20 Holdings Unweighted | — | — | — | — | +109.51% |
Pfizer INC reports $170.37M in US-listed equity holdings across 17 positions in its most recent 13F filing. Its largest disclosed positions are ALLO (27.6%), CELC (17.4%) and ARVN (16.2%). The top 20 holdings account for 100.02% of reported assets. Its disclosed equity book has returned +34.29% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Pfizer INC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Pfizer INC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 78003). View Pfizer INC’s 13F filings on SEC